Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for Etomidate-Induced Myoclonus
NCT05754762Unknown
- Sponsor
- Yangzhou University
- Start
- Mar 2023
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
01
Overview
Open-label trial of remifentanil in myoclonus (3 arms), sponsored by Yangzhou University. Primary endpoint: The presence of myoclonus at 2 minutes. Status: unknown.
02
Drugs
remifentanil
03
Conditions
myoclonus
Beyond the preview
Go deeper on NCT05754762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05754762.